Patent — available for licensing
Micro-Organ Device Mimics Organ Structures for Lab Testing
A NASA invention available to explore as a licensing opportunity.
About this technology
Overview
NASA Johnson Space Center has developed the Micro-Organ Device (MOD) platform technology that serves as a drug screening system with human or animal cell micro-organs to supplement and reduce animal studies while potentially increasing the success of clinical trials. The technology was originally developed to evaluate pharmaceuticals in zero gravity to accelerate development and validation of countermeasures for humans in space as well as evaluate space and planetary stressors on a biological level. The MOD is a microfluidic device containing a variety of microstructures and assemblies of cells, all designed to mimic a complex in vivo microenvironment by modeling one or more in vivo micro-organ structures, the architectures and composition of the extracellular matrices in the organs of interest, and the in vivo fluid flows. The fully automated technology can be used to perform early stage in vivo drug screening without the use of animal experimentation, saving time, money, and resources. This NASA Technology is available for your company to license and develop into a commercial product. NASA does not manufacture products for commercial sale.